Stocks · Health care · Pharmaceutical Preparations

Enliven Therapeutics, Inc.

ELVN Clue Score23
United States Fiscal year ends December CIK 0001672619 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Lori Anne Kunkel
30 Oct 2026
Director
Exercised, kept
7,300
$18.30
$133.59K
Lori Anne Kunkel
30 Oct 2026
Director
Exercised, kept
3,741
$1.12
$4.19K
Benjamin Hohl
22 Dec 2025
Chief Financial Officer
Exercised, kept
13,000
$2.48
$32.24K
Lori Anne Kunkel
17 Dec 2025
Director
Exercised, kept
15,958
$1.12
$17.87K

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 39
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 482,634
History held since 16 Mar 2020